raloxifene hydrochloride has been researched along with Day Blindness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Del Mar, NA; Doty, JB; Driver, JH; Fortugno, AP; Henderson, DL; Honig, MG; Li, C; Mitchell, WM; Moore, BM; Perry, AM; Ragsdale, TD; Reiner, A | 1 |
1 other study(ies) available for raloxifene hydrochloride and Day Blindness
| Article | Year |
|---|---|
Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene.
Topics: Animals; Brain; Brain Concussion; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Optic Nerve; Raloxifene Hydrochloride; Receptor, Cannabinoid, CB2; Retina; Vision Disorders | 2019 |